How has Pfizer's payments to acquire property, plant, and equipment changed year-over-year?

Pfizer's payments to acquire property, plant, and equipment decreased by 22.7% year-over-year, from $564.00M to $436.00M.

What is the long-term trend for Pfizer's payments to acquire property, plant, and equipment?

Over 4 years (2021 to 2025), Pfizer's payments to acquire property, plant, and equipment has grown at a -0.8% compound annual growth rate (CAGR), from $2.71B to $2.63B.

What does payments to acquire property, plant, and equipment mean?

The amount of cash spent on buying or building long-term physical assets like factories and equipment.

Other

Payments to Acquire Property, Plant, and Equipment

Pfizer Payments to Acquire Property, Plant, and Equipment decreased by 48.4% to $436.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 22.7%, from $564.00M to $436.00M. Over 4 years (FY 2021 to FY 2025), Payments to Acquire Property, Plant, and Equipment shows relatively stable performance with a -0.8% CAGR.

Analysis

StatementIncome Statement

SectionOther

CategoryCapital Allocation

SignalContext dependent

VolatilityModerate

First reportedQ1 2013

Last reportedQ1 2026May 5, 2026

How to read this metric

High levels indicate aggressive investment in expansion or maintenance, while low levels may suggest capital preservation or reduced growth investment.

Detailed definition

Measures the cash outflows used to purchase or construct long-term physical assets, such as machinery, facilities, and i...

Peer comparison

Standard capital expenditure (CapEx) metric used across all industries to evaluate investment strategy.

Metric ID: other_payments_to_acquire_property_plant_and_equipment

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$537.00M	$618.00M	$1.00B	$643.00M	$751.00M	$841.00M	$1.00B	$1.14B	$914.00M	$810.00M	$1.04B	$704.00M	$637.00M	$651.00M	$917.00M	$564.00M	$618.00M	$602.00M	$845.00M	$436.00M
QoQ Change	—	+15.1%	+62.1%	-35.8%	+16.8%	+12.0%	+19.0%	+13.8%	-19.8%	-11.4%	+28.9%	-32.6%	-9.5%	+2.2%	+40.9%	-38.5%	+9.6%	-2.6%	+40.4%	-48.4%
YoY Change	—	—	—	—	+39.9%	+36.1%	-0.1%	+77.1%	+21.7%	-3.7%	+4.3%	-38.2%	-30.3%	-19.6%	-12.2%	-19.9%	-3.0%	-7.5%	-7.9%	-22.7%

Range$436.00M – $1.14B

CAGR-4.3%

Avg YoY Growth+0.9%

Median YoY Growth-5.6%

Payments to Acquire Property, Plant, and Equipment at Other Companies

AmgenAMGN View metric

Roivant SciencesROIV View metric

BiogenBIIB View metric

ALN

Alnylam PharmaceuticalsALNY View metric

West Pharmaceutical ServicesWST View metric

Vertex PharmaceuticalsVRTX View metric

Frequently Asked Questions

What is Pfizer's payments to acquire property, plant, and equipment?: Pfizer (PFE) reported payments to acquire property, plant, and equipment of $436.00M in Q1 2026.
How has Pfizer's payments to acquire property, plant, and equipment changed year-over-year?: Pfizer's payments to acquire property, plant, and equipment decreased by 22.7% year-over-year, from $564.00M to $436.00M.
What is the long-term trend for Pfizer's payments to acquire property, plant, and equipment?: Over 4 years (2021 to 2025), Pfizer's payments to acquire property, plant, and equipment has grown at a -0.8% compound annual growth rate (CAGR), from $2.71B to $2.63B.
What does payments to acquire property, plant, and equipment mean?: The amount of cash spent on buying or building long-term physical assets like factories and equipment.